ACTIVE

Cryptobiotix

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
1,8 M €
+49.8% YoY
Gross margin
3,9 M €
+56.4% YoY
Equity
3,7 M €
+86.9% YoY
Workforce
15,8 ETP
+68.1% YoY

What does Cryptobiotix do?

Cryptobiotix is a Public limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 15,8 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0762.565.104
Incorporation
27/01/2021
Legal form
Public limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
61 500,00 €
Latest accounts
31/12/2025
Average workforce
15,8 ETP
Activities (NACE)
72101Research and experimental development on natural sciences and engineering· main72110Research and experimental development on biotechnology71209Technical testing and analysis71209Technical testing and analysis
Joint committees (3)
  • 1000
  • 207
  • 2070
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin3,9 M €2,5 M €1,6 M €883,7 k €317,4 k €
EBITDA2,5 M €1,6 M €952,1 k €710,2 k €274,3 k €
Operating result2,3 M €1,5 M €837,6 k €662,5 k €239,2 k €
Net result1,8 M €1,2 M €618,5 k €501,6 k €187,7 k €
Balance sheet
Equity3,7 M €2,0 M €1,2 M €593,1 k €201,5 k €
Total assets5,7 M €4,2 M €2,7 M €1,8 M €631,1 k €
Cash572,4 k €2,3 M €1,5 M €509,6 k €226,6 k €
Debts633,0 k €999,2 k €785,0 k €664,2 k €401,3 k €
Other
Workforce15,8 ETP9,4 ETP8,3 ETP2,6 ETP1,2 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 2 ended

Active mandates

AB Initio Management

Director · since 01 juillet 2025 · 1024.944.956

Represented by Baudot Aurélien

Active
PVDA Biosciences

Director · since 01 juillet 2025 · 1025.196.364

Represented by Van den Abbeele Pieter

Active
Aurélien Baudot

Managing director · since 24 mars 2021 · until 30 juin 2025

Active
Pieter Van den Abbeele

Managing director · since 24 mars 2021 · until 30 juin 2025

Active

Ended mandates

Aurélien Baudot

Managing director · since 27 janvier 2021 · until 15 mai 2027

Ended
Pieter Van den Abbeele

Managing director · since 27 janvier 2021 · until 15 mai 2027

Ended
At this address

Other companies at this address

CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
INNOVATIVE PHARMACEUTICS● Active
0883.574.582
Inspect● Active
0645.950.417
INVIBES ADVERTISING● Active
0836.533.938
KYTOS● Active
0768.755.286
Lares Solutions● Active
1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active
0755.350.975
Microbial Resource Management Health● Active
0742.910.132
Microbial Resource Management Technologies● Active
0667.765.816
Annual accounts

Full financial information

20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202227/01/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months12 months
Filing date30/06/202611/06/202527/05/202422/06/202319/04/2022
General meeting29/06/202612/05/202529/04/202430/03/202324/01/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/06/202630/06/2026DutchPDF
Abridged model31/12/202412/05/202511/06/2025DutchPDF
Abridged model31/12/202329/04/202427/05/2024DutchPDF
Abridged model31/12/202230/03/202322/06/2023DutchPDF
Abridged model31/12/202124/01/202219/04/2022DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 2 ended

Active mandates

AB Initio Management

Director · since 01 juillet 2025 · 1024.944.956

Represented by Baudot Aurélien

Active
PVDA Biosciences

Director · since 01 juillet 2025 · 1025.196.364

Represented by Van den Abbeele Pieter

Active
Aurélien Baudot

Managing director · since 24 mars 2021 · until 30 juin 2025

Active
Pieter Van den Abbeele

Managing director · since 24 mars 2021 · until 30 juin 2025

Active

Ended mandates

Aurélien Baudot

Managing director · since 27 janvier 2021 · until 15 mai 2027

Ended
Pieter Van den Abbeele

Managing director · since 27 janvier 2021 · until 15 mai 2027

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates15/05/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other24/07/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates18/05/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other29/01/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20251,8 M €↑
  2. 2024
    Annual accounts 20241,2 M €↑
  3. 2023
    Annual accounts 2023618,5 k €↑
  4. 2022
    Annual accounts 2022501,6 k €↑
  5. 2021
    Annual accounts 2021187,7 k €
  6. 27/01/2021
    IncorporationPublic limited company